Clinical trials: Anterior Myocardial Infarction
- Condition Anterior Myocardial Infarction
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Anterior Myocardial Infarction
A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects
Acute Myocardial Infarction (AMI) is an acute ischemic necrosis that occurs following acute stenosis or occlusion of the coronary arteries, and it is associated with a high morbidity and mortality rate.
- Trial name
- NCT07079618
- Testing
- SGC001
- Where
- China
- Volunteers
- 49 people, healthy volunteers welcome
- Sponsor
- Beijing Sungen Biomedical Technology Co., Ltd
Acute Myocardial Infarction, STEMI
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
A multi-center randomized post-approval evaluation of delivery of intracoronary hyperoxemic supersaturated Oxygen therapy for 60 minutes in anterior AMI patients with successful reperfusion (via PCI) within 6 hours after onset of…
- Trial name
- NCT04743245
- Testing
- TherOx DownStream System, PCI
- Where
- United States
- Volunteers
- 17 people, healthy volunteers welcome
- Sponsor
- TherOx